Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Acta Paediatr ; 90(3): 242-9, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11332161

ABSTRACT

UNLABELLED: Parenteral lipids are susceptible to light-induced peroxidation, particularly under phototherapy. Ascorbic acid is protective. The aim of this study was to investigate whether dark delivery tubing and/or coadministration of multivitamin preparations could prevent peroxidation of Intralipid without undue vitamin loss. In experiments carried out on the benchtop, lipid peroxidation occurred in ambient light and was more extensive under phototherapy. Dark tubing decreased peroxide formation, but only by about 65%. In simulated clinical conditions in which solutions were pumped through standard clear or dark minibore plastic tubing. Intralipid accumulated lipid peroxides as measured by the FOX assay (280 microM) or as triglyceride hydroperoxides (52 microM). Multivitamin preparations (MVIP or Soluvit/Vitlipid) inhibited peroxide formation almost completely, and were fully protective when used with dark tubing. There was loss of riboflavin (65% from Soluvit and 35% from MVIP) in clear tubing but this was decreased to 18% and 11%, respectively, in dark tubing. Ascorbate loss was 20% (MVIP) and 50% (Soluvit) and only slightly less in dark tubing. Ascorbate loss was also seen in the absence of Intralipid and is due to riboflavin-induced photo-oxidation. CONCLUSION: Multivitamin preparations protect Intralipid against light-induced formation of lipid hydroperoxides, and administering multivitamins with Intralipid via dark delivery tubing provides a practical way of preventing peroxidation of the lipid while limiting vitamin loss. This procedure should be considered for routine use as well as with phototherapy.


Subject(s)
Fat Emulsions, Intravenous/metabolism , Food, Formulated , Light/adverse effects , Lipid Peroxidation , Parenteral Nutrition , Vitamins/metabolism , Ascorbic Acid , Humans , Infant, Newborn , Infant, Premature , Lipid Peroxidation/radiation effects , Parenteral Nutrition/instrumentation , Phototherapy , Riboflavin , Vitamin E
2.
J Pediatr ; 136(4): 473-80, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10753245

ABSTRACT

BACKGROUND: Low selenium (SE) status has been documented in preterm infants and has been suggested to be a risk factor for chronic lung disease. METHODS: A total of 534 infants with birth weight <1500 g were enrolled in 8 New Zealand centers in a double-blind placebo-controlled randomized trial of SE supplementation from week 1 of life until 36 weeks' postmenstrual age or discharge home. Supplemented infants received 7 microg/kg/d of SE when fed parenterally and 5 microg/kg/d when fed orally. Plasma SE and glutathione peroxidase concentrations were measured in mothers after delivery and in infants before randomization and at 28 days and 36 weeks' postmenstrual age. Primary outcome measures were oxygen dependency at 28 days and total days oxygen dependency. RESULTS: No significant differences were seen between the groups with respect to primary or secondary outcome measures, with the exception that fewer supplemented infants had an episode of sepsis after the first week of life (P <.038). Mean plasma SE concentrations were 0.33 micromol/L before randomization in both groups and at 28 days had risen in the supplemented group (0.56 micromol/L) but fallen in the control group (0.29 micromol/L) (P <.0001). There was no association between outcome measures and SE concentrations at 28 days or 36 weeks' postmenstrual age. However, lower maternal and infant prerandomization SE concentrations were associated with increased respiratory morbidity. CONCLUSIONS: Postnatal SE supplementation in very low birth weight infants did not improve neonatal outcome. Further investigation of SE supplementation of mothers from the second half of pregnancy is warranted.


Subject(s)
Infant, Very Low Birth Weight , Pregnancy Outcome , Selenium/administration & dosage , Double-Blind Method , Female , Glutathione Peroxidase/blood , Humans , Hyaline Membrane Disease/blood , Hyaline Membrane Disease/therapy , Infant , Infant, Newborn , Male , Oxygen Inhalation Therapy , Parenteral Nutrition , Pregnancy , Selenium/blood , Time Factors
3.
Br J Surg ; 86(10): 1296-301, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10540137

ABSTRACT

BACKGROUND: Ascorbic acid (AA) is an important endogenous antioxidant in plasma and has been shown to be decreased at the time of hospital admission in patients with acute pancreatitis. The aim of this study was to determine whether plasma AA concentration continues to decrease after admission and whether the extent of decrease is related to the severity of pancreatitis. METHODS: Consecutive patients with mild (n = 62) and severe (n = 23) acute pancreatitis had plasma AA concentration measured on the day of recruitment and on days 2 and 5 by high-performance liquid chromatography. RESULTS: The plasma AA concentration in patients with acute pancreatitis was significantly less than that in normal volunteers on days 0, 2 and 5 (P < 0.0001) and this was more marked in those with severe disease. There was a decrease in plasma AA concentration from day 0 to day 2 in patients with mild (P < 0.0001) and severe (P = 0.0005) pancreatitis, and from day 2 to day 5 in patients with severe pancreatitis (P = 0.023). CONCLUSION: Endogenous plasma AA continues to decrease over the first 5 days in hospital and the extent is related to the severity of acute pancreatitis. Presented to a meeting of the Australasian Surgical Research Society, Auckland, New Zealand, August 1995 and published in abstract form as Aust N Z J Surg 1996; 66: 243


Subject(s)
Ascorbic Acid/blood , Pancreatitis/blood , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Female , Humans , Male , Middle Aged , Pancreatitis/etiology , Pancreatitis/urine , Time Factors , Treatment Outcome
4.
Pediatr Pulmonol ; 23(3): 217-21, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9094731

ABSTRACT

Endotracheal suctioning in the neonatal intensive care setting is a routine procedure performed to maintain patency of the airway in ventilated infants. Harvested material can also be a source of mucus for research into neonatal respiratory disorders. We aimed to investigate whether the composition of material obtained by our clinically preferred technique of dry shallow suctioning differed significantly from that obtained with saline lavage and deep suctioning. Eleven pairs of dry and saline lavage aspiration samples were compared for neutrophil enzyme myeloperoxidase, total and active alpha(1)-antitrypsin, alpha(1)-antitrypsin complexed with elastase, and secretory leukoprotease inhibitor. Even though individual values of each analyte, expressed per gram of albumin, varied over at least a fivefold range, there was no difference between mean values of dry and lavage samples for any of the constituents. We conclude that the yield of material for research obtained by dry shallow suctioning is adequate and the quality at least as satisfactory as that provided by saline lavage.


Subject(s)
Mucus , Suction/methods , Bronchoalveolar Lavage Fluid/chemistry , Humans , Infant , Infant, Newborn , Intubation, Intratracheal , Membrane Proteins/analysis , Mucus/chemistry , Peroxidase/analysis , Proteinase Inhibitory Proteins, Secretory , Proteins/analysis , Serine Proteinase Inhibitors/analysis , Specimen Handling/methods , alpha 1-Antitrypsin/analysis
5.
Free Radic Biol Med ; 23(3): 361-6, 1997.
Article in English | MEDLINE | ID: mdl-9214571

ABSTRACT

We describe a new immunoassay for measuring protein carbonyls as an index of oxidative injury. Protein samples were reacted with dinitrophenylhydrazine then adsorbed to wells of an ELISA plate before probing with a commercial antibody raised against protein-conjugated dinitrophenylhydrazine. The biotin-conjugated primary antibody was then reacted with streptavidin-biotinylated horseradish peroxidase for quantification. The method was calibrated using oxidized albumin and results correlated well with the colorimetric carbonyl assay. The method required only 60 microg protein and was used to analyze the amount of protein carbonyls in plasma and lung aspirate samples. It was sensitive in the 0-2.5 nmol/mg protein range within which clinical samples fell and was linear up to 10 nmol/mg protein. The ELISA method for protein carbonyls is more sensitive and discriminatory than the colorimetric assay and should have wide application for analysing experimental and clinical samples, especially where concentrations are low and where only small amounts of sample are available.


Subject(s)
Enzyme-Linked Immunosorbent Assay/methods , Oxidative Stress , Proteins/analysis , 2,4-Dinitrophenol/immunology , Antibodies/immunology , Bronchoalveolar Lavage Fluid/chemistry , Calibration , Colorimetry , Humans , Proteins/chemistry , Reproducibility of Results , Sensitivity and Specificity , Serum Albumin, Bovine/analysis
6.
Acta Paediatr ; 85(9): 1116-22, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8888929

ABSTRACT

The objective of this study was to examine the relationship between malondialdehyde-thiobarbituric acid (MDA-TBA) levels, as a measure of lipid peroxidation, in very low birthweight (VLBW) infants and outcome measures. A prospective observational longitudinal study was carried out in two level III neonatal units in the South Island of New Zealand measuring MDA-TBA levels in 61 VLBW infants in 1993. MDA-TBA levels were measured in (i) maternal plasma within 48 h of parturition, (ii) cord plasma, and (iii) infants' plasma at 2, 7, 14 and 28 days of age and correlated with antenatal and postnatal factors. Elevated levels of plasma MDA-TBA at 7 days were associated with adverse respiratory and ophthalmological outcome in the VLBW infants. Elevated MDA-TBA levels were measured at sample times close to the time of death in the infants who died. These results substantiate previously reported preliminary observations and support the hypothesis that oxidative injury, particularly within the first 7 days of life, is associated with the development of the long-term complications of the pre-term infant. MDA-TBA levels appear to be a useful measure to continue to explore the role of free radical mediated disease in the VLBW infant.


Subject(s)
Infant, Premature, Diseases/blood , Infant, Very Low Birth Weight/blood , Lipid Peroxidation , Thiobarbituric Acid Reactive Substances/metabolism , Fat Emulsions, Intravenous , Female , Fetal Blood/metabolism , Free Radicals , Humans , Infant, Newborn , Infant, Premature, Diseases/mortality , Linear Models , Logistic Models , Longitudinal Studies , Male , Parenteral Nutrition, Total , Prognosis , Prospective Studies , Respiration, Artificial
7.
Pediatrics ; 96(2 Pt 1): 314-9, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7630691

ABSTRACT

OBJECTIVE: To examine the relationship between plasma and erythrocyte selenium and glutathione peroxidase (GPx) levels in premature infants and outcome measures. DESIGN: Prospective observational longitudinal study. SETTING: Two regional neonatal intensive care units in the South Island of New Zealand, an area with low soil selenium. PATIENTS: Seventy-nine infants with birth weights less than 1500 g or gestation less than 32 weeks admitted within 48 hours of birth from November 1992 through November 1993. MAIN OUTCOME MEASURES: Oxygen requirement at 28 days (chronic lung disease), or 36 weeks postmenstrual age and for all or most of the time from birth (bronchopulmonary dysplasia), total days in oxygen, retinopathy of prematurity, periventricular hemorrhage, or ventricular dilatation. RESULTS: Initial infant plasma selenium and GPx levels were about two thirds of maternal levels and fell a further 30% in 28 days. In contrast to adults, there was a poor correlation in infant plasma between selenium and GPx at birth and 28 days. Plasma selenium at 28 days was significantly lower in infants with chronic lung disease and bronchopulmonary dysplasia. After controlling for gestational age and age when fully fed orally, 28-day plasma selenium was significantly associated with the log of total days of oxygen requirement, each drop of 0.1 mumol/L in 28-day selenium being associated with a 58% increase in days of oxygen dependency. No significant associations of other parameters of selenium status and respiratory outcome were found, and there were no significant associations of any parameters of selenium status with other outcome measures. CONCLUSIONS: This study demonstrates for the first time in human infants that low plasma selenium levels are significantly associated with an increased respiratory morbidity. Whether selenium deficiency is etiologically important in determining the respiratory outcome or the result of sickness in the infant should be investigated in a randomized, controlled trial.


Subject(s)
Infant, Low Birth Weight/blood , Infant, Premature, Diseases/etiology , Infant, Premature/blood , Respiratory Distress Syndrome, Newborn/etiology , Selenium/blood , Bronchopulmonary Dysplasia/blood , Bronchopulmonary Dysplasia/etiology , Cerebral Hemorrhage/blood , Cerebral Hemorrhage/etiology , Cerebral Ventricles/pathology , Chronic Disease , Erythrocytes/enzymology , Erythrocytes/metabolism , Female , Gestational Age , Glutathione Peroxidase/blood , Humans , Infant, Newborn , Infant, Premature, Diseases/blood , Longitudinal Studies , Male , Oxygen Inhalation Therapy , Plasma , Prospective Studies , Respiratory Distress Syndrome, Newborn/blood , Retinopathy of Prematurity/blood , Retinopathy of Prematurity/etiology
8.
J Paediatr Child Health ; 31(4): 339-44, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7576895

ABSTRACT

OBJECTIVE: New Zealand soils are deficient in the essential micronutrient, selenium. New Zealand infants have low selenium levels at birth and experience a further decline if fed cows milk based formula. This study examined the selenium status of infants fed with a new commercially available selenium supplemented formula. METHODOLOGY: Forty-four newborn infants, whose mothers wished to formula feed, were randomized in an open controlled trial to be fed a commercially available selenium supplemented cows milk formula (containing 17 micrograms Se/L) or an unsupplemented formula (containing 4.6 micrograms Se/L). Cord, 1 and 3 month blood samples were obtained for selenium status (plasma and red cell selenium and glutathione peroxidase) and thyroid function. RESULTS: Mean plasma selenium and glutathione peroxidase values were significantly higher in supplemented than unsupplemented infants at 1 month (unpaired t-tests; P < 0.0001 and P = 0.001 respectively) and 3 months (P < 0.0001 and P = 0.0005). Analysis within treatment groups between time points (paired t-tests) showed that selenium supplementation prevented the fall in plasma selenium from birth to 1 month seen in unsupplemented infants and was associated with a rise in levels between 1 and 3 months (P = 0.002). CONCLUSIONS: Supplementing cows milk formula with selenium to replicate the levels found in breast milk is nutritionally sound. Feeding from a few days of age with a formula containing 17 micrograms Se/L in infants with low selenium status at birth is sufficient to cause a rise to 80% of adult levels at 3 months of age.


Subject(s)
Food, Fortified , Infant Food , Selenium/administration & dosage , Selenium/blood , Analysis of Variance , Female , Fetal Blood/chemistry , Glutathione Peroxidase/blood , Growth , Humans , Infant , Male , New Zealand , Selenium/physiology , Thyroid Gland/metabolism
9.
J Pediatr ; 126(5 Pt 1): 785-90, 1995 May.
Article in English | MEDLINE | ID: mdl-7752007

ABSTRACT

Vitamin E can be a prooxidant in isolated lipoprotein suspensions. Because lipid emulsions used in parenteral nutrition are lipoprotein-like suspensions rich in polyunsaturated fatty acids and vitamin E, we hypothesized that vitamin E may act as a prooxidant in lipid emulsions, as it is in lipoprotein suspensions. We therefore exposed an intravenously administered lipid emulsion (Intralipid) to a single spotlight commonly used in the treatment of neonatal jaundice, and measured the formation of triglyceride hydroperoxides by using high-performance liquid chromatography with postcolumn chemiluminescence detection. Concentrations of these hydroperoxides in different batches of fresh intralipid were usually approximately 10 mumol/L but increased up to 60 times after exposure to phototherapy light for a period of 24 hours, even though significant amounts of vitamin E were present at the end of the exposure. Triglyceride hydroperoxides were formed during phototherapy light exposure whether the intralipid was in plastic tubing used routinely for infusion or in glass containers. Ambient light also caused significant peroxidation of the formula lipids, although to a much lesser extent than observed with phototherapy light. For infants in the neonatal intensive care unit who were receiving intralipid but not phototherapy, solutions being infused at the end of 24 hours contained a mean of 40 mumol/L hydroperoxides. For infants receiving phototherapy, the mean was 97 mumol/L. Phototherapy light-induced formation of triglyceride hydroperoxides was prevented by covering the intralipid with aluminum foil or supplementation with sodium ascorbate before light exposure. We conclude that intralipid is highly susceptible to oxidation and that elevated levels of oxidized lipids can be formed during its clinical use, especially when intralipid infusion is combined with phototherapy. Because lipid hydroperoxides are cytotoxic and can cause adverse effects, inadvertent infusion of rancid intralipid may add to the numerous problems encountered by premature neonates.


Subject(s)
Fat Emulsions, Intravenous/radiation effects , Light/adverse effects , Parenteral Nutrition , Phototherapy/adverse effects , Radiation Protection/methods , Aluminum , Chromatography, High Pressure Liquid , Drug Interactions , Fat Emulsions, Intravenous/therapeutic use , Glass , Humans , Infant, Newborn , Infusions, Intravenous , Jaundice, Neonatal/metabolism , Jaundice, Neonatal/therapy , Lipid Peroxidation , Models, Theoretical , Oxidation-Reduction , Plastics , Time Factors , Triglycerides/metabolism , Vitamin E/metabolism
10.
Eur Respir J ; 7(2): 251-9, 1994 Feb.
Article in English | MEDLINE | ID: mdl-7909297

ABSTRACT

We wanted to identify the inhibitors of neutrophil elastase, quantify their activities in the upper airways of neonates, and relate these to the presence of active elastase and the likelihood of elastolytic injury occurring due to inhibitory capacity being overwhelmed. Activities of neutrophil elastase and its inhibitors were measured in tracheal aspirates from 17 infants, 10 of whom subsequently developed bronchopulmonary dysplasia. All aspirates contained immunologically detectable alpha 1-proteinase inhibitor (alpha 1-PI), but their inhibitory capacity against neutrophil elastase ranged from being undetectable to being in excess of the amount of alpha 1-PI detected immunologically. When the alpha 1-PI was removed from each of the aspirates, using a specific antibody, from 0-50% of the original activity remained, indicating the presence of another elastase inhibitor. Its properties were consistent with it being the low molecular mass, secretory leucoproteinase inhibitor (SLPI), also known as bronchial antileucoproteinase. The alpha 1-PI was from 0-100% active. Most of the inactive inhibitor was shown by western blotting to be complexed with elastase, with a small amount of cleaved material. There was no evidence of major oxidative inactivation. Free elastase was detected in only three of the aspirates; these had little or no detectable elastase inhibitory capacity, and most of their alpha 1-PI was complexed. Elastase load, comprising the sum of free and complexed elastase, correlated closely with myeloperoxidase activity, a recognized marker of inflammatory activity. Active SLPI levels showed a positive correlation with gestational age (r = 0.66). We conclude that most neutrophil elastase in the upper airways of ventilated infants is complexed.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Bronchopulmonary Dysplasia/metabolism , Lung/metabolism , Pancreatic Elastase/metabolism , Proteins , Respiratory Distress Syndrome, Newborn/metabolism , Serine Proteinase Inhibitors/metabolism , alpha 1-Antitrypsin/metabolism , Blotting, Western , Bronchopulmonary Dysplasia/etiology , Female , Humans , Infant, Newborn , Leukocyte Elastase , Leukocytes/metabolism , Male , Proteinase Inhibitory Proteins, Secretory , Secretory Leukocyte Peptidase Inhibitor , Suction , Trachea
11.
Pediatr Res ; 32(2): 189-94, 1992 Aug.
Article in English | MEDLINE | ID: mdl-1508608

ABSTRACT

By world standards, the selenium status of the adult population of Christchurch, New Zealand is low. To determine the status of infants undergoing neonatal intensive care, plasma and red cell selenium and glutathione peroxidase levels were measured in infants admitted to the regional neonatal unit. Plasma levels in all newborn infants were one third to one half those in adults. Premature infants had levels significantly lower than those in cord blood from term infants, but their levels were not different from those of term infants admitted to the unit. There were no differences between adult and infant red cell levels. The premature infants remaining in the neonatal unit showed dramatic decreases in plasma selenium and glutathione peroxidase with age, with many infants having selenium levels of less than 0.13 mumol/L (10 micrograms/L). Low levels were seen in infants fed orally as well as those on parenteral nutrition. Thus, the low selenium status of New Zealanders is associated with particularly low selenium levels in premature infants. Because these infants have a high risk for oxidative diseases such as bronchopulmonary dysplasia (chronic lung disease) and retinopathy of prematurity, the possibility that these conditions are more serious in the New Zealand population needs to be assessed and consideration given to dietary supplementation.


Subject(s)
Glutathione Peroxidase/blood , Infant, Premature/blood , Selenium/blood , Adult , Age Factors , Bronchopulmonary Dysplasia/etiology , Diet , Erythrocytes/metabolism , Female , Fetal Blood/metabolism , Humans , Infant , Infant, Newborn , Male , New Zealand , Nutritional Status , Selenium/administration & dosage , Selenium/deficiency
12.
N Z Med J ; 105(932): 139-42, 1992 Apr 22.
Article in English | MEDLINE | ID: mdl-1495647

ABSTRACT

OBJECT: New Zealanders, because of a soil deficiency, have a low intake of selenium. To determine the impact of this on the infant population in Christchurch. METHODS: we have measured red cell and plasma selenium and the selenoenzyme, glutathione peroxidase, in 70 infants less than 12 months old and related these to age and diet. RESULTS: the infant population as a whole had mean plasma levels of selenium and glutathione peroxidase of 33 micrograms/L and 97 U/L compared with adult values of 74 micrograms/L and 150 U/L. Infant red cell levels of 0.30 mu g selenium and 9.0 U glutathione peroxidase per g haemoglobin were similar to those in adults. The selenium status of most breast fed infants after birth remained similar to that of cord blood. Mean plasma selenium and glutathione peroxidase levels in formula fed infants were about half those of breast fed infants, and their red cell selenium was also significantly lower. These did not increase until solids were introduced into the diet. The status of the infants reflected their diet, with the concentration of selenium in formulae being 3.9-5.2 micrograms/mL compared with a mean of 13.4 micrograms/mL in breast milk. CONCLUSIONS: since infants in more replete selenium areas show a gradual rise in blood selenium parameters after birth, this study suggests that formula fed and some breast fed infants in Christchurch receive an inadequate selenium intake. Consideration should be given to supplementing infant formulae and perhaps also the diet of pregnant and/or breast feeding mothers.


Subject(s)
Diet , Infant Food/analysis , Milk, Human/chemistry , Selenium/analysis , Adult , Animals , Erythrocytes/chemistry , Female , Fetal Blood/chemistry , Glutathione Peroxidase/analysis , Glutathione Peroxidase/blood , Humans , Infant , Infant, Newborn , Male , Milk/analysis , New Zealand , Selenium/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...